NCT03637569

Brief Summary

In this study, the investigators aim to demonstration of relationship between triceps skinfold thickness and overall survival of pancreatic cancer, cholangiocarcinoma and GB cancer.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
5mo left

Started Apr 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Apr 2018Dec 2026

Study Start

First participant enrolled

April 1, 2018

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 26, 2018

Completed
25 days until next milestone

First Posted

Study publicly available on registry

August 20, 2018

Completed
6.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

August 25, 2023

Status Verified

August 1, 2023

Enrollment Period

7.1 years

First QC Date

July 26, 2018

Last Update Submit

August 24, 2023

Conditions

Pancreas CancerCholangiocarcinomaGallbladder Cancer

Outcome Measures

Primary Outcomes (1)

  • Overall survival

    The duration between diagnosis and death

    through study completion, an average of 2 year

Study Arms (1)

Cancer patients

Newly diagnosed pancreatic, bile duct or GB cancer patients at samsung medical center.

Other: Measurement of triceps skinfold thickness

Interventions

Measurement of triceps skinfold thicknessOTHER

By using skin thickness caliper, measure triceps skinfold thickness on the half of forearm (Rt side). In every 3 weeks, triceps skinfold thickness will be measured.

Cancer patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who visit and treated at Samsung medical center.

You may qualify if:

  • Newly diagnosed pancreatic, bile duct or gallbladder cancer patients, undergoing therapeutic management (including surgery, chemotherapy or palliative care).
  • Age above 18 years old

You may not qualify if:

  • Other malignant disease
  • Underlying intestinal disease that cause absorprtion disorder
  • Underlying psychiatric disorder such as eating disorder (bulimia, anorexia)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsung Medical Center

Seoul, South Korea

RECRUITING

MeSH Terms

Conditions

Pancreatic NeoplasmsCholangiocarcinomaGallbladder Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System DiseasesAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeBiliary Tract NeoplasmsBiliary Tract DiseasesGallbladder Diseases

Central Study Contacts

Jong-In Chnag, M.D.

CONTACT

82-2-3410-3409ji.chang@samsung.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 26, 2018

First Posted

August 20, 2018

Study Start

April 1, 2018

Primary Completion

April 30, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

August 25, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations

KR(1)